Sandoz Group AG (OTCMKTS:SDZNY - Get Free Report) shot up 0.8% during trading on Monday . The company traded as high as $45.85 and last traded at $45.69. 25,020 shares traded hands during trading, a decline of 74% from the average session volume of 97,949 shares. The stock had previously closed at $45.32.
Wall Street Analyst Weigh In
Separately, Royal Bank of Canada cut Sandoz Group from a "moderate buy" rating to a "hold" rating in a report on Monday, September 16th.
View Our Latest Research Report on Sandoz Group
Sandoz Group Price Performance
The stock has a 50-day moving average of $43.63 and a 200-day moving average of $40.51.
Sandoz Group Company Profile
(
Get Free Report)
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Further Reading
Before you consider Sandoz Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sandoz Group wasn't on the list.
While Sandoz Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
